Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ETX

E-therapeutics (ETX)

E-therapeutics Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:ETX
日付受信時刻ニュースソース見出しコード企業名
2024/05/0915 : 00RNS Regulatory NewsAIM Cancellation - e-Therapeutics PlcLSE:ETXE-therapeutics Plc
2024/05/0815 : 00RNS Regulatory Newse-Therapeutics plc Last Day of Dealings on AIMLSE:ETXE-therapeutics Plc
2024/05/0402 : 00RNS Regulatory NewsFTSE Russell e-therapeuticsLSE:ETXE-therapeutics Plc
2024/04/2922 : 09RNS Regulatory Newse-Therapeutics plc Result of General MeetingLSE:ETXE-therapeutics Plc
2024/04/1018 : 48Alliance NewsAlliance Newse-Therapeutics says company faces lack of interest as UK listingLSE:ETXE-therapeutics Plc
2024/04/1015 : 00RNS Regulatory Newse-Therapeutics plc Proposed Fundraise of £28.9m and CancellationLSE:ETXE-therapeutics Plc
2024/02/0101 : 30RNS Regulatory Newse-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
2024/01/2419 : 04UK Regulatorye-Therapeutics plc Exercise of Options and Issue of EquityLSE:ETXE-therapeutics Plc
2024/01/1619 : 34Alliance NewsAlliance NewsIN BRIEF: e-Therapeutics shares rise on strong financial yearLSE:ETXE-therapeutics Plc
2024/01/1616 : 00UK Regulatorye-Therapeutics plc Business UpdateLSE:ETXE-therapeutics Plc
2024/01/1001 : 04UK Regulatorye-Therapeutics plc Director Dealing and Issue of EquityLSE:ETXE-therapeutics Plc
2023/12/2719 : 27Alliance NewsAlliance NewsIN BRIEF: e-Therapeutics shares to cease trading on OTCQXLSE:ETXE-therapeutics Plc
2023/12/2716 : 00UK Regulatorye-Therapeutics plc Update on OTCQX Market ListingLSE:ETXE-therapeutics Plc
2023/11/0223 : 34Alliance NewsAlliance NewsEARNINGS AND TRADING: Kanabo inks CBD deal, Taseko boosts productionLSE:ETXE-therapeutics Plc
2023/11/0216 : 00UK Regulatorye-Therapeutics plc Strategic RWE collaboration with ArcturisLSE:ETXE-therapeutics Plc
2023/10/2702 : 12Alliance NewsAlliance NewsEARNINGS: Riverstone Credit stays stable, Bloomsbury hails record halfLSE:ETXE-therapeutics Plc
2023/10/2615 : 38UK Regulatorye-Therapeutics plc Interim results for the six months to 31 July 2023LSE:ETXE-therapeutics Plc
2023/10/1917 : 54UK Regulatorye-Therapeutics plc Notice of Interim ResultsLSE:ETXE-therapeutics Plc
2023/09/3000 : 30UK Regulatorye-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
2023/09/2022 : 37Alliance NewsAlliance NewsTRADING UPDATES: Capital inks contract; Lansdowne becomes cash shellLSE:ETXE-therapeutics Plc
2023/09/2015 : 00UK Regulatorye-Therapeutics plc Senior Management UpdateLSE:ETXE-therapeutics Plc
2023/09/0719 : 47UK Regulatorye-Therapeutics plc Exercise of Options and Issue of EquityLSE:ETXE-therapeutics Plc
2023/08/0100 : 30UK Regulatorye-Therapeutics plc Total Voting RightsLSE:ETXE-therapeutics Plc
2023/07/1900 : 20UK Regulatorye-Therapeutics plc Result of Annual General MeetingLSE:ETXE-therapeutics Plc
2023/07/0701 : 27UK Regulatorye-Therapeutics plc Director Dealing and Issue of EquityLSE:ETXE-therapeutics Plc
2023/06/3015 : 00RNS Non-Regulatorye-Therapeutics plc Investor PresentationLSE:ETXE-therapeutics Plc
2023/06/2615 : 00RNS Non-Regulatorye-Therapeutics plc Notice of Investor PresentationLSE:ETXE-therapeutics Plc
2023/05/1115 : 00UK Regulatorye-Therapeutics plc Notice of AGM and Posting of Annual ReportLSE:ETXE-therapeutics Plc
2023/05/0503 : 37Alliance NewsAlliance NewsTRADING UPDATES: Virgin Wines warns sales will be below City forecastsLSE:ETXE-therapeutics Plc
2023/05/0415 : 00UK Regulatorye-Therapeutics plc Final results for the year ended 31 January 2023LSE:ETXE-therapeutics Plc
 Showing the most relevant articles for your search:LSE:ETX